High Flow Nasal Cannula Market

High Flow Nasal Cannula Market: Global Industry Analysis 2015-2019 and Opportunity Assessment 2020-2030

  • Ongoing
  • July 2020
  • REP-GB-11269
  • PDF PPT EXCEL
High Flow Nasal Cannula Market
  • SELECT LICENSE TYPE :

  • US$5,000
  • US$7,500
  • US$10,000

This High Flow Nasal Cannula market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving High Flow Nasal Cannula market.


Escalating urbanization and industrialization have led to soaring air pollution levels in both developing and developed countries. Air pollution coupled with increasing smoking is leading to asthma, a medical condition where the respiratory airways swell, causing difficulty in breathing, and wheezing, coughing and repetitive instances of breathlessness.

The severity and occurrence of these symptoms vary individually. Over the years, the High Flow Nasal Cannula (HFNC) methodology has remained one of the most prominent methods in assisting patients with respiratory issues, and is poised for a significant growth rate on the back of high adoption. The key factor that bolsters the HFNC market is the growing need for asthma treatment, chronic obstructive pulmonary disease (COPD) therapeutics, and the COVID-19 pandemic management which is highly infectious and causing acute respiratory distress in a small percentage of the afflicted population

Asthma: Predominant Driver of Application, Production Further Ramps up with COIVID-19 Pandemic

According to a report by the World Health Organization (WHO), approximately 235 million people suffer from asthma around the world. Furthermore, the Centers for Disease Control and Prevention (CDC) claims that 7.7% of adults in the U.S., accounting for a whopping 19 Million, suffer from asthma.

The high flow nasal cannula methodology is a highly utilized healthcare service to treat such respiratory illnesses, thereby giving an impetus to the market. The outbreak of COVID-19, which predominantly affects the respiratory system, is giving substantial revenue opportunities to the players in the HFNC market. This is further expected to create a spike in demand for HFNC systems.

Market Growth Analysis

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

COVID -19 : Impact Analysis

Request the coronavirus impact analysis across industries and markets

Request Covid -19 Impact

Active Humidifier to be Highly Preferred in HFNC Market

On the basis of the component, the global high-flow nasal cannula market is segmented into air/oxygen blender, nasal cannulas, active humidifier, single heated tube, and other consumables. Active humidifier component currently holds the majority of share in terms of value, and is expected to continue its dominance in the future, on the back of continuous innovations by manufacturers and high adoption.

The air/oxygen blender market closely follows the active humidifier and remains the second most lucrative component. The applications of air/oxygen blenders are projected to grow in the foreseeable future, owing to growing adoption among healthcare solution providers.

Asthma and COPD to Accelerate Demand for HFNC Methodologies

High-flow nasal cannula methodology is utilized to give relief to patients suffering from acute respiratory failure, chronic obtrusive pulmonary disease, sleep apnea, bronchiectasis, and carbon monoxide toxicity, among other breathing-related disorders. Among the medical applications, treatment for acute respiratory failure is one of the foremost applications with the highest market share due to the high prevalence of acute respiratory failure in newborns, children, and adults. The Chronic Obstructive Pulmonary Disease (COPD) follows close behind acute respiratory failure and is projected to remain the second most lucrative application for the HFNC systems.

Hospitals Remain Major End User

HFNC systems are majorly used in ambulatory care centers, long-term care centers, and hospitals. Hospitals are poised to be influential revenue drivers for the global high-flow nasal cannula market. Among the aforementioned end users, hospitals occupy the lion's share in driving the revenue to the global market due to the high admission rates of patients with these diseases. The share of ambulatory care centers is expected to witness a surge on the back of increasing adoption of these systems for applications in emergency cases.

North America Leads Backed by Favorable Initiatives, Europe Buckling Up

Invigorated by positive factors such as rising awareness, affordability, and favorable healthcare and reimbursement initiatives, North America is dominating the global HFNC market with a significant chunk in global market value. The growth is further complemented by the growing number of asthma patients in the region.

European is the second most lucrative region behind North America in the global high-flow nasal cannula market, and is projected to grow at a significant rate. Similarly, Asia Pacific is anticipated to outpace other regions and will exhibit a higher growth rate vis-a-vis other regions. The demand for HFNC systems is accelerating in Asia Pacific owing to improving health care policies in the emerging economies of the region.

COVID-19 Pandemic to Spur Sales

The global outbreak of coronavirus is attacking the respiratory systems of the patients, thus leading to breathing difficulties. To assist in breathing, the high-flow nasal cannula (HFNC), is finding extensive applications in hospitals and healthcare centers. With cases of COVID-19 exploding over the world, HFNC is a befitting methodology in helping patients breathe by providing free flow of oxygen.

Conventional oxygen therapy does not efficiently tolerate high flow rates due to deficiencies of unheated and non-humidified oxygen. To overcome these shortcomings, the high-flow nasal cannulas are used owing to their ability to control heat and humidity, subsequently improving patient tolerance and comfort.

Among various ventilation techniques available in the market, the technique is to be chosen depending on each patient's condition. To deliver successful clinical results, there are different types of Non-Invasive Ventilation (NIV) Techniques. One such highly used technique is HFNC, in which oxygen is delivered to patients with mild hypoxemic respiratory failure:

Competitive Landscape of Global HFNC Market

Some of the prominent players in the global high flow nasal cannula market are Fisher &Paykel Healthcare Limited, Teleflex Incorporated, Teijin Pharma Limited, TNI medical AG, ResMed, Inc., Becton, Dickinson and Company, MEK-ICS CO., LTD., Hamilton Medical, Smiths Medical, Vapotherm, Inc., Flexicare Medical Limited, Salter Labs, and Great Group Medical Co., Ltd. among others. The competitive landscape of the global HFNC market is shaped by approvals on new products and strategic partnerships. Recently, Teleflex acquired Vascular Solutions to enhance Teleflex's business of interventional procedures

Why choose FMI?

  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte

Unique Requirements? Customize this Report

  • Customize by Region, Country, Application, Product, & other segments
  • Integrate our Insights with your Existing Data
  • Determine the scope of the study to suit your requirements

Let FMI Help You!

  • Gain Insights on Key High Flow Nasal Cannula Market Impacting Forces
  • Know the Winning Strategies of Market Leaders
  • Get Deep-Dive Analysis on Each Segment
  • Identify the Sources that will Drive Top-Line Revenue

Key Taxonomy: Global High-Flow Nasal Cannula

On the Basis of Component

  • Air/oxygen blender
  • Nasal Cannulas
  • Active Humidifier
  • Single Heated tube

On the Basis of Application

  • Bronchiectasis
  • Acute Respiratory Failure
  • Acute Heart Failure
  • Chronic Obstructive Pulmonary Disease (COPD)

On the Basis of End-User

  • Hospitals
  • Ambulatory Care Centers
  • Long-Term Care Centers
  • Global High Flow Nasal Cannula Market

On the Basis of Geography

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)
  • Latin America

Report Highlights: Global High Flow Nasal Cannula Market

  • An overview of evolving market dynamics in the medical nasal cannula devices industry
  • Detailed segmentation of high flow nasal cannula market
  • Historical, current, and prospective examination of market size in terms of value and volume
  • Recent developments and influential trends in high flow nasal cannula market
  • Opportunity assessment of high flow nasal cannula market
  • Competitive landscape analysis of high flow nasal cannula marketplace
Frequently Asked Questions

Why choose FMI?
  • With a global presence and a trusted partner to several Fortune 500 firms, FMI covers 1 billion+ data points to build a diversified portfolio for market benchmarking
  • Market Reports researched and peer reviewed by industry experts from across the globe
  • We follow a multi-dimensional method of analysis monitoring a three-layer data validation process
  • In addition to demand-side market assessment, our data triangulation methodology involves supply-side research
  • Primary research includes mandatory field interviews with stakeholders involved
  • Customizing reports according to client specification is also our forte
  • The current and future market size, covering each aspect and nuanced trends across key national and geographic markets
  • An overview of the market report, providing an imperative visual of the varied market subdivisions and overall forecast statistics in terms of value and volume
  • Extensive database and key dynamics elevating the market with varied verticals associated
  • Underlying High Flow Nasal Cannula Market forces that are compelling consumers or businesses to purchase the product
  • How novel technologies and consumer-centric innovations will create new value-adding opportunities for companies active in the High Flow Nasal Cannula Market
  • What will be environment and regulatory impacts on the market over the next decade
  • Investment Feasibility Matrix - It shows returns on investment, level of competition, success rate of investment, and potential risks associated with the market. The analysis shows that the competition is high in the established market, while the returns for short-term investment are also taken into consideration
  • Relative Maturity Mapping – The relative maturity is measured according to three growth phases (growth, maturity, decline)
  • Relative PLC (Product Life Cycle) – Analysis of the emergence of prominent players and competitive test prices which are driving factors behind every market. (expected market behavior, observed market behavior, expected market performance, observed market performance)
Get in touch
Harish Tiwari

Harish Tiwari

Global Head - Business Development

Akshay Godge

Akshay Godge

Client Partner - Global Business Development

Our Clients


Request Sample Request customization Request Methodology